Related Experiment Video

Updated: Jun 25, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time

C J Terkelsen1, E H Christiansen, J T Sørensen

  • 1Department of Cardiology B, Aarhus University Hospital, Skejby, Denmark. Christian_juhl_terkelsen@hotmail.com

Heart (British Cardiac Society)
|February 17, 2009
PubMed

Insights

Current guidelines suggest a 60-minute window for primary percutaneous coronary intervention (PPCI) in ST-elevation myocardial infarction (STEMI). This viewpoint advocates for an extended PPCI time window of 80-120 minutes, emphasizing its superiority for reperfusion.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Emergency Medicine

Background:

  • Controversy exists regarding optimal timing for primary percutaneous coronary intervention (PPCI) in ST-elevation myocardial infarction (STEMI).
  • Current guidelines recommend PPCI over fibrinolysis if the PCI-related delay is less than 60 minutes and presentation delay exceeds 3 hours.

Purpose of the Study:

  • To review existing literature on PPCI time windows for STEMI patients.
  • To propose revisions to current American and European guidelines regarding PPCI eligibility and timing.

Main Methods:

  • Literature review of studies evaluating PPCI and fibrinolysis in STEMI.
  • Analysis of time-dependent outcomes and logistical considerations for reperfusion strategies.

Main Results:

  • Evidence supports an extended PCI-related delay of 80-120 minutes for PPCI.
  • PPCI is identified as a superior reperfusion strategy, even for early presenters.
  • The time-dependency of PPCI compared to fibrinolysis is questioned.

Conclusions:

  • Guidelines for PPCI in STEMI should be revised to reflect evidence supporting longer acceptable delays.
  • Optimal logistics involve prehospital diagnosis and direct transfer to 24/7 catheterization labs to maximize PPCI eligibility.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...